Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Listerine Gum Therapy is an over-the-counter antiseptic mouthwash developed by Johnson & Johnson. It is formulated with a specific blend of four essential oils—eucalyptol, menthol, methyl salicylate, and thymol—which act as antimicrobial agents. The product is specifically indicated for the treatment and reversal of early gum disease (gingivitis), targeting symptoms such as gum redness, swelling, and bleeding. By penetrating the dental plaque biofilm to kill plaque-causing bacteria, it helps reduce plaque buildup and improve overall gingival health. It is recognized by the American Dental Association (ADA) for its efficacy in reducing plaque and gingivitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Listerine Gum Therapy.